On this page
Terry L Savage
Insider
First SEC filing: Jan. 2, 2004 · Latest: Jan. 2, 2004
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 25, 2024 | CME | A | 748 | $194.10 | $145,187 | 18,189 Indirect | +4.29% | Acquired | 39.2% (price as of 2026-10-06) |
| May 13, 2024 | CME | S | 2,500 | $210.65 | $526,625 | 17,441 Indirect | -12.54% | Disposed | 28.3% (price as of 2026-10-06) |
| June 26, 2023 | CME | A | 811 | $178.89 | $145,080 | 19,941 Indirect | +4.24% | Acquired | 51.0% (price as of 2026-10-06) |
| June 27, 2022 | CME | A | 693 | $209.44 | $145,142 | 19,130 Indirect | +3.76% | Acquired | 29.0% (price as of 2026-10-06) |
| Jan. 25, 2022 | CME | A | 47 | $221.79 | $10,424 | 18,437 Indirect | +0.26% | Acquired | 21.8% (price as of 2026-10-06) |
| June 25, 2021 | CME | A | 551 | $218.12 | $120,184 | 18,390 Indirect | +3.09% | Acquired | 23.9% (price as of 2026-10-06) |
| June 25, 2020 | CME | A | 712 | · | · | 17,839 Indirect | +4.16% | Acquired | (price as of 2026-10-06) |
| June 25, 2019 | CME | A | 606 | · | · | 17,127 Indirect | +3.67% | Acquired | (price as of 2026-10-06) |
| Sept. 25, 2018 | CME | A | 87 | · | · | 16,521 Indirect | +0.53% | Acquired | (price as of 2026-10-06) |
| June 25, 2018 | CME | A | 601 | · | · | 16,434 Indirect | +3.80% | Acquired | (price as of 2026-10-06) |
| June 26, 2017 | CME | A | 809 | · | · | 15,833 Indirect | +5.38% | Acquired | (price as of 2026-10-06) |
| June 27, 2016 | CME | A | 1,075 | · | · | 15,024 Indirect | +7.71% | Acquired | (price as of 2026-10-06) |
| June 27, 2016 | CME | A | 1,075 | · | · | 1,075 Indirect | · | Acquired | (price as of 2026-10-06) |
| June 25, 2015 | CME | A | 1,064 | · | · | 13,949 Indirect | +8.26% | Acquired | (price as of 2026-10-06) |
| June 25, 2015 | CME | A | 1,064 | · | · | 12,885 Indirect | +9.00% | Acquired | (price as of 2026-10-06) |
| Aug. 25, 2014 | CME | A | 331 | · | · | 12,885 Indirect | +2.64% | Acquired | (price as of 2026-10-06) |
| June 25, 2014 | CME | A | 1,062 | · | · | 12,554 Indirect | +9.24% | Acquired | (price as of 2026-10-06) |
| June 25, 2013 | CME | A | 982 | · | · | 11,492 Indirect | +9.34% | Acquired | (price as of 2026-10-06) |
| June 25, 2012 | CME | A | 281 | · | · | 2,102 Indirect | +15.43% | Acquired | (price as of 2026-10-06) |
| June 27, 2011 | CME | A | 267 | · | · | 1,821 Indirect | +17.18% | Acquired | (price as of 2026-10-06) |
| June 27, 2011 | CME | A | 267 | · | · | 1,821 Indirect | +17.18% | Acquired | (price as of 2026-10-06) |
| May 25, 2010 | CME | A | 241 | · | · | 1,554 Indirect | +18.35% | Acquired | (price as of 2026-10-06) |
| May 26, 2009 | CME | A | 247 | · | · | 1,313 Indirect | +23.17% | Acquired | (price as of 2026-10-06) |
| May 27, 2008 | CME | A | 166 | · | · | 1,066 Indirect | +18.44% | Acquired | (price as of 2026-10-06) |
| May 25, 2007 | CME | A | 147 | · | · | 900 Indirect | +19.52% | Acquired | (price as of 2026-10-06) |
| Aug. 25, 2006 | CME | A | 53 | · | · | 753 Indirect | +7.57% | Acquired | (price as of 2026-10-06) |
| May 25, 2006 | CME | A | 100 | · | · | 100 Direct | · | Acquired | (price as of 2026-10-06) |
| May 25, 2005 | CME | A | 100 | · | · | 600 Direct | +20.00% | Acquired | (price as of 2026-10-06) |
| Dec. 31, 2003 | MCD | A | 473 | · | · | 473 Direct | · | Acquired | (price as of 2026-10-06) |
| Dec. 1, 2003 | MCD | A | 722 | · | · | 722 Direct | · | Acquired | (price as of 2026-10-06) |
| Nov. 24, 2003 | MCD | M | 2,000 | $14.38 | $28,760 | 0 Direct | -100.00% | Disposed | 1516.5% (price as of 2026-10-06) |
| Nov. 24, 2003 | MCD | S | 2,000 | $25.40 | $50,800 | 0 Direct | -100.00% | Disposed | 815.2% (price as of 2026-10-06) |
| Nov. 24, 2003 | MCD | M | 2,000 | $14.38 | $28,760 | 2,000 Direct | · | Acquired | 1516.5% (price as of 2026-10-06) |
| Sept. 30, 2003 | MCD | A | 627 | · | · | 627 Direct | · | Acquired | (price as of 2026-10-06) |
| Aug. 20, 2003 | CME | P | 300 | $72.60 | $21,780 | 500 Direct | +150.00% | Acquired | 1760.7% (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 31, 2003 | MCD | Phantom Stock | Common Stock | · | · | 473 | Acquired |
| Dec. 1, 2003 | MCD | Phantom Stock | Common Stock | · | · | 722 | Acquired |
| Nov. 24, 2003 | MCD | Options (Right to Buy) | Common Stock | $14.38 | Jan. 19, 2005 | 2,000 | Disposed |
| Sept. 30, 2003 | MCD | Phantom Stock | Common Stock | · | · | 627 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).